fda and glp 1 Patient education tips for GLP-1, weight loss drug treatment Readout Newsletter: FDA GLP-1 labels,
Description
The study shows that in addition to improving glycemic control, GLP-1RAs reduce major adverse renal events in diabetic patients [61]
Those numbers are significant
The third action, which I think is also critical, is it causes a person to feel full
11.8 per 100 person-years, p = 0.34)
It also doesn't take payments through HSA or FSA programs
New England Journal of Medicine , 387 (3), 205216
